Open original FDA record ↗Recall record
- FDA identifier
- Z-0297-2025
- Company in FDA record
- Boston Scientific Corporation
- FDA classification date
- Nov 12, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Boston Scientific is updating the instructions for use of their POLARx and POLARx FIT Cryoablation Balloon Catheters related to Atrio-esophageal Fistula Risk.
Source facts
- Action
- Boston Scientific disseminated a letter to Physicians/Healthcare Professionals on 10/10/2024 via courier. The letter notified its consignees of updates to the instructions for use (IFU) for the POLARx and POLARx FIT Cryoablation Catheter related to the risk of atrioesophageal (AE) fistula. The firm requested that the information be shared with clinicians who use the use the Boston Scientific POLARx Cryoablation System, including the POLARx Catheter, the POLARx FIT Catheter and the SMARTFREEZE Console, and to share the communication with any other organization to which these devices may have been transferred. Users were directed to immediately post the information on or near the product to ensure this information is easily accessible to all users of the device.
- Initiated
- 2024-10-10
- Root cause
- Device Design
- Distribution
- Worldwide
- Recall number
- Z-0297-2025
- Recall status
- Open, Classified
- CDRH record ID
- 210462
- FDA classified
- 2024-11-12
- Recall event number
- 95514